We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Apple, Nike, Qualcomm, eBay and DTE Energy
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 30, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL - Free Report) , Nike, Inc. (NKE - Free Report) , Qualcomm Inc. (QCOM - Free Report) , eBay Inc. (EBAY - Free Report) and DTE Energy Company (DTE - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Research Reports for Apple, Nike and Qualcomm
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Nike, Inc. and Qualcomm Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Apple’s shares have outperformed the Zacks Computer - Mini computers industry on a year to date basis (+57.8% vs. +55.3%). The Zacks analyst believes that the company’s focus on strengthening the Services business and a strong slate of upcoming app releases, including its streaming service Apple TV+, are key catalysts. The company is also expected to benefit from the launch of latest iPhones, refreshed Macbook, iPad and Apple Watch product lines.
However, the ongoing U.S.-China trade war does not bode well for the company. Legal woes have increased due to a lawsuit from customers related to App Store charges. The company has also been accused of unfair practices by Spotify.
Nike’s shares have outperformed the Zacks Shoes and Retail Apparel industry over the past one-year period (+21.9% vs. +19.3%). The Zacks analyst believes that NIKE will continue investing in key capabilities to aid digital transformation and deliver robust growth in fiscal 2020 and beyond. Further, it expects results for fiscal 2020 to be driven by brand recognition, robust innovation pipeline, and positive response from Nike Direct and wholesale partners.
However, higher SG&A expenses and tax rate, as well as adverse currency are headwinds. The company expects SG&A expenses to increase high-single digit in second-quarter fiscal 2020. Further, the company is likely to witness prominent impacts from the recently-enacted tariffs in the fiscal second quarter, which should partly mar the gross margin.
Qualcomm’s shares have outperformed the Zacks Wireless Equipment industry so far this year (+45.9% vs. +17.2%). The Zacks analyst believes that Qualcomm has been trying to retain its leadership in 5G, chipset market and mobile connectivity with several technological achievements and innovative product launches. The company has redefined the computing and mobile ecosystem across the globe with the launch of QCA6390 Connectivity SoC product.
However, aggressive competition in the mobile phone chipset market from low-cost rival chipmakers and leading smartphone makers is likely to hurt Qualcomm. Margins have also decreased sharply due to high operating expenses and R&D costs.
Other noteworthy reports we are featuring today include eBay Inc. and DTE Energy Company.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Apple, Nike, Qualcomm, eBay and DTE Energy
For Immediate Release
Chicago, IL – October 30, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL - Free Report) , Nike, Inc. (NKE - Free Report) , Qualcomm Inc. (QCOM - Free Report) , eBay Inc. (EBAY - Free Report) and DTE Energy Company (DTE - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Top Research Reports for Apple, Nike and Qualcomm
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Nike, Inc. and Qualcomm Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Apple’s shares have outperformed the Zacks Computer - Mini computers industry on a year to date basis (+57.8% vs. +55.3%). The Zacks analyst believes that the company’s focus on strengthening the Services business and a strong slate of upcoming app releases, including its streaming service Apple TV+, are key catalysts. The company is also expected to benefit from the launch of latest iPhones, refreshed Macbook, iPad and Apple Watch product lines.
However, the ongoing U.S.-China trade war does not bode well for the company. Legal woes have increased due to a lawsuit from customers related to App Store charges. The company has also been accused of unfair practices by Spotify.
Nike’s shares have outperformed the Zacks Shoes and Retail Apparel industry over the past one-year period (+21.9% vs. +19.3%). The Zacks analyst believes that NIKE will continue investing in key capabilities to aid digital transformation and deliver robust growth in fiscal 2020 and beyond. Further, it expects results for fiscal 2020 to be driven by brand recognition, robust innovation pipeline, and positive response from Nike Direct and wholesale partners.
However, higher SG&A expenses and tax rate, as well as adverse currency are headwinds. The company expects SG&A expenses to increase high-single digit in second-quarter fiscal 2020. Further, the company is likely to witness prominent impacts from the recently-enacted tariffs in the fiscal second quarter, which should partly mar the gross margin.
Qualcomm’s shares have outperformed the Zacks Wireless Equipment industry so far this year (+45.9% vs. +17.2%). The Zacks analyst believes that Qualcomm has been trying to retain its leadership in 5G, chipset market and mobile connectivity with several technological achievements and innovative product launches. The company has redefined the computing and mobile ecosystem across the globe with the launch of QCA6390 Connectivity SoC product.
However, aggressive competition in the mobile phone chipset market from low-cost rival chipmakers and leading smartphone makers is likely to hurt Qualcomm. Margins have also decreased sharply due to high operating expenses and R&D costs.
Other noteworthy reports we are featuring today include eBay Inc. and DTE Energy Company.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.